Palagani, V., & Giese, N. (2014). Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression. Carcinogenesis, 35(4), . https://doi.org/10.1093/carcin/bgt394
Chicago Style (17th ed.) CitationPalagani, Vindhya, and Nathalia Giese. "Combined Inhibition of Notch and JAK/STAT Is Superior to Monotherapies and Impairs Pancreatic Cancer Progression." Carcinogenesis 35, no. 4 (2014). https://doi.org/10.1093/carcin/bgt394.
MLA (9th ed.) CitationPalagani, Vindhya, and Nathalia Giese. "Combined Inhibition of Notch and JAK/STAT Is Superior to Monotherapies and Impairs Pancreatic Cancer Progression." Carcinogenesis, vol. 35, no. 4, 2014, https://doi.org/10.1093/carcin/bgt394.
Warning: These citations may not always be 100% accurate.